DexCom, Inc.
NASDAQ:DXCM · NASDAQ Global Select
+$0.90 today
Vol 7.63M · Avg 5.43M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-9.23%
Period High
$89.53
Period Low
$54.84
Latest
$72.47
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Teva Pharmaceutical Industries Limited
NYSE:TEVA
$36.61B
Biogen Inc.
NASDAQ:BIIB
$29.01B
Koninklijke Philips N.V.
NYSE:PHG
$26.03B
Waters Corporation
NYSE:WAT
$23.19B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.14B
Labcorp Holdings Inc.
NYSE:LH
$20.95B
STERIS plc
NYSE:STE
$19.65B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.05B
Smith & Nephew plc
NYSE:SNN
$12.74B
Insulet Corporation
NASDAQ:PODD
$9.99B
What is the latest DXCM filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does DXCM have?
Intrinsic Alpha currently shows 20 recent filings for DXCM.
Explore More
Continue the stock analysis
Jump to another research area for this company.